UA83928C2 - Производное пропан-1,3-диона или его соль - Google Patents
Производное пропан-1,3-диона или его сольInfo
- Publication number
- UA83928C2 UA83928C2 UAA200612631A UAA200612631A UA83928C2 UA 83928 C2 UA83928 C2 UA 83928C2 UA A200612631 A UAA200612631 A UA A200612631A UA A200612631 A UAA200612631 A UA A200612631A UA 83928 C2 UA83928 C2 UA 83928C2
- Authority
- UA
- Ukraine
- Prior art keywords
- compound
- propane
- gnrh receptor
- drugs
- useful
- Prior art date
Links
- WSMYVTOQOOLQHP-UHFFFAOYSA-N Malondialdehyde Chemical class O=CCC=O WSMYVTOQOOLQHP-UHFFFAOYSA-N 0.000 title abstract 3
- 150000003839 salts Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical group C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 abstract 3
- 102000008238 LHRH Receptors Human genes 0.000 abstract 3
- 108010021290 LHRH Receptors Proteins 0.000 abstract 3
- 230000008485 antagonism Effects 0.000 abstract 2
- 239000008280 blood Substances 0.000 abstract 2
- 210000004369 blood Anatomy 0.000 abstract 2
- 201000010099 disease Diseases 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 229940079593 drug Drugs 0.000 abstract 2
- 206010006187 Breast cancer Diseases 0.000 abstract 1
- 208000026310 Breast neoplasm Diseases 0.000 abstract 1
- 206010020880 Hypertrophy Diseases 0.000 abstract 1
- 206010060862 Prostate cancer Diseases 0.000 abstract 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 abstract 1
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical group C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 abstract 1
- 206010046798 Uterine leiomyoma Diseases 0.000 abstract 1
- 230000001419 dependent effect Effects 0.000 abstract 1
- 230000000857 drug effect Effects 0.000 abstract 1
- 210000004696 endometrium Anatomy 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 239000003163 gonadal steroid hormone Substances 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 230000003993 interaction Effects 0.000 abstract 1
- 230000002503 metabolic effect Effects 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
- 210000002307 prostate Anatomy 0.000 abstract 1
- 239000002464 receptor antagonist Substances 0.000 abstract 1
- 229940044551 receptor antagonist Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Предложены соединения, которые полезны в качестве антагонистов рецептора GnRH. В изобретении дополнительно изучены производные пропан-1,3-диона и подтверждено, что пропан-1,3-дион, который содержит 2-(1,3-дигидро-2Н-бензимидазол-2-илиден), или соединение, которое содержит бензольное или тиофеновое кольцо, замещенное производной 1-гидроксиметила, проявляет хорошую доступность, в дополнение к ее хорошей антагонистической активности относительно рецептора GnRH, что приводит к осуществлению изобретения. Поскольку соединение изобретения проявляет хорошу�
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2004166486 | 2004-06-04 | ||
| JP2005099815 | 2005-03-30 | ||
| PCT/JP2005/010184 WO2005118556A1 (ja) | 2004-06-04 | 2005-06-02 | プロパン-1,3-ジオン誘導体又はその塩 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA83928C2 true UA83928C2 (ru) | 2008-08-26 |
Family
ID=35462868
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200612631A UA83928C2 (ru) | 2004-06-04 | 2005-06-02 | Производное пропан-1,3-диона или его соль |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US7709519B2 (ru) |
| EP (1) | EP1752452A4 (ru) |
| JP (1) | JP4595938B2 (ru) |
| CN (1) | CN1964950A (ru) |
| AR (1) | AR049436A1 (ru) |
| AU (1) | AU2005250273B2 (ru) |
| BR (1) | BRPI0511796A (ru) |
| CA (1) | CA2568590C (ru) |
| IL (1) | IL179437A (ru) |
| MX (1) | MXPA06014131A (ru) |
| NO (1) | NO20070074L (ru) |
| NZ (1) | NZ552372A (ru) |
| RU (1) | RU2347781C2 (ru) |
| TW (1) | TWI342307B (ru) |
| UA (1) | UA83928C2 (ru) |
| WO (1) | WO2005118556A1 (ru) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4595938B2 (ja) | 2004-06-04 | 2010-12-08 | アステラス製薬株式会社 | プロパン−1,3−ジオン誘導体又はその塩 |
| JP4715845B2 (ja) * | 2005-03-31 | 2011-07-06 | アステラス製薬株式会社 | プロパン−1,3−ジオン誘導体又はその塩 |
| EP2095818A1 (en) | 2008-02-29 | 2009-09-02 | AEterna Zentaris GmbH | Use of LHRH antagonists at non-castrating doses |
| EP3915367A1 (en) * | 2010-08-18 | 2021-12-01 | BioSplice Therapeutics, Inc. | Diketones and hydroxyketones as catenin signaling pathway activators |
| US9527818B2 (en) | 2012-09-07 | 2016-12-27 | Astellas Pharma Inc. | Method for producing sulfonyl amidine compound |
| HRP20190142T1 (hr) | 2013-02-22 | 2019-03-22 | Samumed, Llc | Gama-diketoni kao aktivatori signalizacijskog puta wnt/beta-katenina |
| US9618507B2 (en) | 2014-02-24 | 2017-04-11 | Betanien Hospital | Methods of treating rheumatoid arthritis |
| BR112017003959B1 (pt) | 2014-08-20 | 2022-08-02 | Samumed, Llc | Uso de um composto de fórmula i ou um sal dermatologicamente aceitável do mesmo |
| JP2017529388A (ja) | 2014-08-26 | 2017-10-05 | ベタニエン ホスピタル | 炎症性病態の治療のための方法、薬剤および組成物 |
| CN109311806A (zh) * | 2016-03-31 | 2019-02-05 | 富士胶片富山化学株式会社 | 新的异羟肟酸衍生物的制造方法及其中间体 |
Family Cites Families (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4062686A (en) | 1976-04-21 | 1977-12-13 | Eastman Kodak Company | Sensitizers for photocrosslinkable polymers |
| US4263393A (en) | 1979-09-06 | 1981-04-21 | Eastman Kodak Company | Novel electron donor precursors and photographic element containing them |
| JPS56161538A (en) | 1980-05-16 | 1981-12-11 | Mitsubishi Chem Ind Ltd | Photosensitive composition |
| NZ197714A (en) | 1980-07-15 | 1984-11-09 | Glaxo Group Ltd | Substituted pyrimidin-2-ones and pharmaceutical compositions |
| JPS5964840A (ja) | 1982-10-05 | 1984-04-12 | Mitsubishi Chem Ind Ltd | 感光性組成物 |
| GB8312721D0 (en) | 1983-05-09 | 1983-06-15 | Vickers Plc | Photoinitiators |
| GB8321813D0 (en) | 1983-08-12 | 1983-09-14 | Vickers Plc | Radiation sensitive compounds |
| DE3333450A1 (de) | 1983-09-16 | 1985-04-11 | Hoechst Ag, 6230 Frankfurt | Trihalogenmethylgruppen enthaltende carbonylmethylenheterocyclen, verfahren zu ihrer herstellung und lichtempfindliches gemisch, das diese verbindungen enthaelt |
| DD224422A1 (de) | 1984-04-27 | 1985-07-03 | Wolfen Filmfab Veb | Lichtempfindliches farbfotografisches silberhalogenidmaterial |
| JPH0760265B2 (ja) | 1985-07-02 | 1995-06-28 | 三菱化学株式会社 | 感光性組成物 |
| JPH0820729B2 (ja) | 1986-07-25 | 1996-03-04 | 三菱化学株式会社 | 染色可能な感光性組成物 |
| JPH0820695B2 (ja) | 1987-04-30 | 1996-03-04 | 富士写真フイルム株式会社 | ハロゲン化銀感光材料 |
| JPH01205130A (ja) | 1988-02-10 | 1989-08-17 | Fuji Photo Film Co Ltd | 非線形光学材料 |
| DE3807381A1 (de) | 1988-03-07 | 1989-09-21 | Hoechst Ag | 4,6-bis-trichlormethyl-s-triazin-2-ylgruppen enthaltende heterocyclische verbindungen, verfahren zu ihrer herstellung und lichtempfindliches gemisch, das diese verbindung enthaelt |
| EP0333156A3 (en) | 1988-03-16 | 1990-03-21 | Fuji Photo Film Co., Ltd. | Lithographic plate necessitating no dampening water |
| JPH01249792A (ja) | 1988-03-30 | 1989-10-05 | Nippon Kayaku Co Ltd | 新規なオキセタン誘導体およびその製造法 |
| JPH087437B2 (ja) | 1988-08-19 | 1996-01-29 | 富士写真フイルム株式会社 | 光重合性組成物 |
| JPH0279007A (ja) | 1988-09-16 | 1990-03-19 | Sumitomo Electric Ind Ltd | 被覆光ファイバ |
| JPH0766168B2 (ja) | 1988-10-04 | 1995-07-19 | 富士写真フイルム株式会社 | ハロゲン化銀カラー写真感光材料 |
| DE68921146T2 (de) | 1988-11-11 | 1995-06-14 | Fuji Photo Film Co Ltd | Lichtempfindliche Zusammensetzung. |
| JP2639722B2 (ja) | 1989-01-18 | 1997-08-13 | 富士写真フイルム株式会社 | 感光性組成物 |
| US5112743A (en) | 1989-05-24 | 1992-05-12 | Fuji Photo Film Co., Ltd. | Light-sensitive composition and presensitized plate for use in making lithographic printing plates |
| US4950640A (en) | 1989-06-16 | 1990-08-21 | Eastman Kodak Company | Infrared absorbing merocyanine dyes for dye-donor element used in laser-induced thermal dye transfer |
| JP2552550B2 (ja) | 1989-07-24 | 1996-11-13 | 富士写真フイルム株式会社 | 感光性組成物 |
| JPH03164722A (ja) | 1989-11-24 | 1991-07-16 | Fuji Photo Film Co Ltd | 有機非線形光学材料およびそれを用いた光波長の変換方法 |
| JPH03259150A (ja) | 1990-03-08 | 1991-11-19 | Mitsubishi Kasei Corp | 感光性組成物 |
| JPH04334369A (ja) | 1991-05-02 | 1992-11-20 | Fuji Photo Film Co Ltd | 四級塩化合物、メチン化合物およびメチン化合物の製造方法 |
| JP2764769B2 (ja) | 1991-06-24 | 1998-06-11 | 富士写真フイルム株式会社 | 光重合性組成物 |
| AU662997B2 (en) | 1992-07-03 | 1995-09-21 | Ihara Chemical Industry Co. Ltd. | Condensed heterocyclic derivative and weedkiller |
| JP2955803B2 (ja) | 1992-07-22 | 1999-10-04 | 富士写真フイルム株式会社 | ハロゲン化銀写真感光材料 |
| US5593818A (en) | 1993-06-22 | 1997-01-14 | Fuji Photo Film Co., Ltd. | Silver halide photographic material |
| US5414620A (en) | 1993-08-09 | 1995-05-09 | Honeywell Inc. | Synthetic friction algorithm for a hand control element |
| TW449600B (en) | 1994-04-19 | 2001-08-11 | Takeda Chemical Industries Ltd | Condensed-ring thiophene derivatives, their production and use |
| JP3290316B2 (ja) | 1994-11-18 | 2002-06-10 | 富士写真フイルム株式会社 | 感光性平版印刷版 |
| RU2197964C2 (ru) * | 1995-04-12 | 2003-02-10 | Дзе Проктер Энд Гэмбл Компани | Фармацевтическая композиция, композиция стандартной лекарственной формы и способ лечения злокачественных новообразований, опухолей и вирусных инфекций |
| US6395733B1 (en) | 1995-06-07 | 2002-05-28 | Pfizer Inc | Heterocyclic ring-fused pyrimidine derivatives |
| JPH0961992A (ja) | 1995-08-23 | 1997-03-07 | Fuji Photo Film Co Ltd | 感光性平版印刷版 |
| CA2229201A1 (en) | 1995-10-19 | 1997-04-24 | Satoshi Sasaki | Quinoline derivatives, their production and use |
| JP3506295B2 (ja) | 1995-12-22 | 2004-03-15 | 富士写真フイルム株式会社 | ポジ型感光性平版印刷版 |
| US5747235A (en) | 1996-01-26 | 1998-05-05 | Eastman Kodak Company | Silver halide light sensitive emulsion layer having enhanced photographic sensitivity |
| US5747236A (en) | 1996-01-26 | 1998-05-05 | Eastman Kodak Company | Silver halide light sensitive emulsion layer having enhanced photographic sensitivity |
| US6162813A (en) | 1996-05-20 | 2000-12-19 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
| DE19630229A1 (de) | 1996-07-26 | 1998-01-29 | Bayer Ag | Pyrazinderivate |
| US6140384A (en) | 1996-10-02 | 2000-10-31 | Fuji Photo Film Co., Ltd. | Photopolymerizable composition containing a sensitizing dye with cyano or substituted carbonyl groups |
| US6051359A (en) | 1996-11-25 | 2000-04-18 | Fuji Photo Film Co., Ltd. | Heat developable light-sensitive material and method of forming color images |
| DE69810853T2 (de) | 1997-07-25 | 2004-01-22 | Eastman Kodak Co. | Lichtempfindliche Silberhalogenid-Emulsionsschicht mit erhöhter photographischer Empfindlichkeit |
| US5994051A (en) | 1997-07-25 | 1999-11-30 | Eastman Kodak Company | Silver halide light sensitive emulsion layer having enhanced photographic sensitivity |
| WO1999052888A1 (en) | 1998-04-08 | 1999-10-21 | Washington Odur Ayuko | Butenolide derivatives as anti-cancer agents |
| US6468711B1 (en) | 1998-09-09 | 2002-10-22 | Fuji Photo Film Co., Ltd. | Photosensitive composition and method for manufacturing lithographic printing plate |
| US6346534B1 (en) | 1998-09-23 | 2002-02-12 | Neurocrine Biosciences, Inc. | Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| JP2000095767A (ja) | 1998-09-28 | 2000-04-04 | Takeda Chem Ind Ltd | 性腺刺激ホルモン放出ホルモン拮抗剤 |
| DE19928033A1 (de) | 1999-06-18 | 2000-12-21 | Basf Ag | Verwendung von cyclischen Enaminen als Lichtschutzmittel |
| CN1186326C (zh) | 2000-07-05 | 2005-01-26 | 山之内制药株式会社 | 丙-1,3-二酮衍生物 |
| JP2002088284A (ja) | 2000-09-14 | 2002-03-27 | Fuji Photo Film Co Ltd | インクジェット記録用インク組成物及びインクジェット記録方法 |
| JP2002241758A (ja) | 2001-02-16 | 2002-08-28 | Fuji Photo Film Co Ltd | 液晶組成物および液晶素子 |
| JP2002268239A (ja) | 2001-03-06 | 2002-09-18 | Fuji Photo Film Co Ltd | 印刷版の製版方法 |
| DE60227507D1 (de) | 2001-04-30 | 2008-08-21 | Aeterna Zentaris Gmbh | Niedrigdosierte lhrh antagonisten zur behandlung von neurodegenerativen krankheiten, insbesondere alzheimer krankheit |
| JP2004061583A (ja) | 2002-07-25 | 2004-02-26 | Fuji Photo Film Co Ltd | 平版印刷版の製版方法 |
| JP3902523B2 (ja) | 2002-08-05 | 2007-04-11 | 富士フイルム株式会社 | 光情報記録媒体および情報記録方法 |
| ITMI20031855A1 (it) | 2003-09-29 | 2005-03-30 | Isagro Ricerca Srl | Derivati di 1,3-dioni aventi attivita' erbicida. |
| WO2005097090A2 (en) | 2004-04-05 | 2005-10-20 | Icos Corporation | AGENTS THAT DISRUPT PSD95 - nNOS INTERACTION, COMPOSITIONS CONTAINING THE SAME, AND THERAPEUTIC USES THEREOF |
| JP4595938B2 (ja) | 2004-06-04 | 2010-12-08 | アステラス製薬株式会社 | プロパン−1,3−ジオン誘導体又はその塩 |
-
2005
- 2005-06-02 JP JP2006514134A patent/JP4595938B2/ja not_active Expired - Fee Related
- 2005-06-02 CN CNA2005800182808A patent/CN1964950A/zh active Pending
- 2005-06-02 WO PCT/JP2005/010184 patent/WO2005118556A1/ja not_active Ceased
- 2005-06-02 RU RU2006142689/04A patent/RU2347781C2/ru not_active IP Right Cessation
- 2005-06-02 EP EP05745730A patent/EP1752452A4/en not_active Withdrawn
- 2005-06-02 US US10/588,485 patent/US7709519B2/en not_active Expired - Fee Related
- 2005-06-02 UA UAA200612631A patent/UA83928C2/ru unknown
- 2005-06-02 AU AU2005250273A patent/AU2005250273B2/en not_active Ceased
- 2005-06-02 NZ NZ552372A patent/NZ552372A/xx not_active IP Right Cessation
- 2005-06-02 MX MXPA06014131A patent/MXPA06014131A/es active IP Right Grant
- 2005-06-02 CA CA2568590A patent/CA2568590C/en not_active Expired - Fee Related
- 2005-06-02 BR BRPI0511796-8A patent/BRPI0511796A/pt not_active IP Right Cessation
- 2005-06-03 TW TW094118378A patent/TWI342307B/zh active
- 2005-06-06 AR ARP050102297A patent/AR049436A1/es not_active Application Discontinuation
-
2006
- 2006-11-21 IL IL179437A patent/IL179437A/en not_active IP Right Cessation
-
2007
- 2007-01-04 NO NO20070074A patent/NO20070074L/no not_active Application Discontinuation
-
2010
- 2010-03-18 US US12/726,506 patent/US8076367B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US8076367B2 (en) | 2011-12-13 |
| CN1964950A (zh) | 2007-05-16 |
| RU2006142689A (ru) | 2008-06-10 |
| IL179437A (en) | 2011-11-30 |
| TW200613281A (en) | 2006-05-01 |
| AU2005250273A1 (en) | 2005-12-15 |
| RU2347781C2 (ru) | 2009-02-27 |
| EP1752452A1 (en) | 2007-02-14 |
| MXPA06014131A (es) | 2007-03-07 |
| CA2568590C (en) | 2011-01-18 |
| BRPI0511796A (pt) | 2008-01-15 |
| AR049436A1 (es) | 2006-08-02 |
| NO20070074L (no) | 2007-03-02 |
| AU2005250273B2 (en) | 2010-10-14 |
| IL179437A0 (en) | 2007-05-15 |
| NZ552372A (en) | 2009-11-27 |
| US20100173946A1 (en) | 2010-07-08 |
| TWI342307B (en) | 2011-05-21 |
| US20090018177A1 (en) | 2009-01-15 |
| JPWO2005118556A1 (ja) | 2008-04-03 |
| EP1752452A9 (en) | 2007-12-12 |
| US7709519B2 (en) | 2010-05-04 |
| EP1752452A4 (en) | 2010-07-14 |
| JP4595938B2 (ja) | 2010-12-08 |
| WO2005118556A1 (ja) | 2005-12-15 |
| CA2568590A1 (en) | 2005-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA31084B1 (fr) | Derives de piperidine agonistes de gpcr | |
| TNSN08283A1 (en) | Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use | |
| ZA202006137B (en) | Substituted imidazolidin-2-one derivatives as prmt5 inhibitors | |
| NO20075482L (no) | Propan-1,3-dionderivat og salt derav | |
| EP1641423A4 (en) | BENZODIAZEPINE-CGRP Receptor Antagonists | |
| EP1796678A4 (en) | Carboxamide-spirolactam CGRP Receptor Antagonists | |
| CO6480932A2 (es) | Antagonistas de la trayectoria hedgehog de ftalazina disustituida. | |
| SG179418A1 (en) | Inhibitors of the hedgehog pathway | |
| TW200505903A (en) | CGRP receptor antagonists | |
| EA200900152A1 (ru) | Ингибиторы пирролотриазинкиназы | |
| EA200501322A1 (ru) | Органические соединения железа (iii), их применение и способы получения указанных соединений | |
| CL2008001230A1 (es) | Compuestos derivados de pirrol (2.3-d)pirimidina. purin-6-ilo o pirazol(3,4-d)pirimldina, inhibidores de quinasa p70 s6; composición farmaceutica; y uso para la preparación de medicamentos utiles en el tratamiento de adenocarcinomas del colon e inhibición de angiogénesis. | |
| MX2009000169A (es) | Derivados de purinona como agonistas de hm74a. | |
| MX2021011811A (es) | Protacs que degradan el receptor de estrogeno. | |
| UA83928C2 (ru) | Производное пропан-1,3-диона или его соль | |
| PA8581401A1 (es) | Compuestos de imedazopiridina como agonistas del receptor 5-ht4 | |
| GB0112348D0 (en) | Compounds | |
| EA200300266A1 (ru) | Новые сложные эфиры апорфина и их применение в терапии | |
| CY1114260T1 (el) | 17-υδροξυ-17-πενταφθοροαιθυλο-οιστρα-4,9(10)-διεν-11-αρυλο-παραγωγο, μεθοδοι για την παραγωγη αυτου και χρηση αυτου για την αγωγη παθησεων | |
| MA30757B1 (fr) | Inhibiteurs de l'akt (proteine kinase b) | |
| WO2004017961A3 (en) | Derivatives of 3-hydroxy-4-(cyclyl-alkylaminoalkyl)-5-phenyl-1h-pyrazole as antagonists of the gonadotropin releasing hormone (gnrh) for use in the treatment of sex hormone related conditions, such as prostatic of uterine cancer | |
| MY133512A (en) | Non-steroidal il-5 inhibitors, processes and intermediates for their preparation and pharmaceutical compositions comprising said inhibitors | |
| EP1488807A4 (en) | MEANS FOR THE TREATMENT OF SEXUAL-HORMONE-RELATED DISEASES | |
| DK2201002T3 (da) | 5-HT7-receptorantagonister | |
| AR046672A1 (es) | Prevencion y tratamiento de enfermedaes cardiacas hipertensivas mediante el uso de los estrogenos selectivos 8beta-vinil-estra-1,3,5(10)-trien-3,17beta-diol y 17beta-fluor-9alfa-vinil-estra-1,3,6(10)-trien-3,16alfa-diol |